Investing.com - Harrow Health (NASDAQ: HROW) reported second quarter EPS of $-0.060, $0.12 better than the analyst estimate of $-0.180. Revenue for the quarter came in at $48.94M versus the consensus estimate of $42.51M.
Harrow Health's stock price closed at $21.98. It is up 89.480% in the last 3 months and up 8.490% in the last 12 months.
Harrow Health saw positive EPS revisions and negative EPS revisions in the last 90 days. See Harrow Health's stock price’s past reactions to earnings here.
According to InvestingPro, Harrow Health's Financial Health score is "good performance".
Check out Harrow Health's recent earnings performance, and Harrow Health's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar